Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
August 20, 2009
Fcgamma receptor 1 (CD64), a target beyond cancer
T Thepen, M Huhn, G Melmer, et al.
Biotechniques
|
March 10, 2001
Selection of scFv phages on intact cells under low pH conditions leads to a significant loss of insert-free phages
M K Tur, M Huhn, S Sasse, et al.
Current Pharmaceutical Design
|
August 20, 2009
Improved immunotoxins with novel functional elements
C Hetzel, C Bachran, M K Tur, et al.
Journal of Molecular Biology
|
September 1, 2000
Combining phage display and screening of cDNA expression libraries: a new approach for identifying the target antigen of an scFv preselected by phage display
S Barth, U Weidenmüller, M K Tur, et al.
The British Journal of Dermatology
|
April 30, 2010
Recombinant, ETA'-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice
T Ribbert, T Thepen, M K Tur, et al.
Cancer Research
|
December 26, 2001
Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma
M Huhn, S Sasse, M K Tur, et al.
International Journal of Molecular Medicine
|
September 18, 2004
Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines
A Rothe, A Klimka, M K Tur, et al.
Veterinary and Comparative Oncology
|
August 19, 2011
Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology
J Fitting, D Killian, C Junghanss, et al.
International Journal of Molecular Medicine
|
October 18, 2001
An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines
M K Tur, S Sasse, M Stöcker, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
August 20, 2009
Fcgamma receptor 1 (CD64), a target beyond cancer
T Thepen, M Huhn, G Melmer, et al.
Biotechniques
|
March 10, 2001
Selection of scFv phages on intact cells under low pH conditions leads to a significant loss of insert-free phages
M K Tur, M Huhn, S Sasse, et al.
Current Pharmaceutical Design
|
August 20, 2009
Improved immunotoxins with novel functional elements
C Hetzel, C Bachran, M K Tur, et al.
Journal of Molecular Biology
|
September 1, 2000
Combining phage display and screening of cDNA expression libraries: a new approach for identifying the target antigen of an scFv preselected by phage display
S Barth, U Weidenmüller, M K Tur, et al.
The British Journal of Dermatology
|
April 30, 2010
Recombinant, ETA'-based CD64 immunotoxins: improved efficacy by increased valency, both in vitro and in vivo in a chronic cutaneous inflammation model in human CD64 transgenic mice
T Ribbert, T Thepen, M K Tur, et al.
Cancer Research
|
December 26, 2001
Human angiogenin fused to human CD30 ligand (Ang-CD30L) exhibits specific cytotoxicity against CD30-positive lymphoma
M Huhn, S Sasse, M K Tur, et al.
International Journal of Molecular Medicine
|
September 18, 2004
Construction of phage display libraries from reactive lymph nodes of breast carcinoma patients and selection for specifically binding human single chain Fv on cell lines
A Rothe, A Klimka, M K Tur, et al.
Veterinary and Comparative Oncology
|
August 19, 2011
Generation of recombinant antibody fragments that target canine dendritic cells by phage display technology
J Fitting, D Killian, C Junghanss, et al.
International Journal of Molecular Medicine
|
October 18, 2001
An anti-GD2 single chain Fv selected by phage display and fused to Pseudomonas exotoxin A develops specific cytotoxic activity against neuroblastoma derived cell lines
M K Tur, S Sasse, M Stöcker, et al.
Page
of 1